GlaxoSmithKline
GSK
49.81
-0.92
-1.80%
GlaxoSmithKline
US · GSK
#177 by market cap
Listed 1970
-1.80%
49.81
-0.92
-1.80%
Live - 304 symbols - heartbeat 335s ago
· 2026-09-23 14:59
Pre-market
50.22
-0.99%
After-hours
50.72
0.00%
Overnight
50.28
-0.87%
- Market cap
- 99.78B
- P/E (TTM)i
- 15.84
- P/Bi
- 4.24
- EPSi
- 3.71
- Div yieldi
- 3.56%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on GSK?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 1 analysts
Hold
Avg price target
70.00 +40.5%
Price target rangecurrent 49.81
Low70.00
Avg70.00
High70.00
Buy 0%
Hold 100%
Sell 0%
Recent ratings (10)
| Date | Firm | Rating | Target |
|---|---|---|---|
| 2026-08-03 | TD Cowen | HOLD | 70.00 |
| 2026-06-11 | TD Cowen | HOLD | 70.00 |
| 2026-06-08 | Argus Research | BUY | -- |
| 2026-05-29 | TD Cowen | HOLD | 70.00 |
| 2026-05-29 | Jefferies | BUY | 67.10 |
| 2026-02-09 | TD Cowen | HOLD | 70.00 |
| 2026-01-07 | Jefferies | BUY | 55.60 |
| 2026-01-06 | Barclays | SELL | -- |
| 2025-12-18 | TD Cowen | HOLD | 52.00 |
| 2025-10-29 | BofA Securities | SELL | 23.46 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Day move |
|---|---|---|---|
| 2026/Q3 | 2026-10-28 | -- | -- |
| 2026/Q2 | 2026-07-28 | -- | +3.33% |
| 2026/Q1 | 2026-04-29 | -- | -5.64% |
| 2025/Q4 | 2026-02-04 | -- | +7.29% |
| 2025/Q3 | 2025-10-29 | -- | +5.10% |
| 2025/Q2 | 2025-07-30 | -- | +3.45% |
| 2025/Q1 | 2025-04-30 | -- | +2.26% |
| 2024/Q4 | 2025-02-05 | -- | +8.21% |
| 2024/Q3 | 2024-10-30 | -- | -3.04% |
| 2024/Q2 | 2024-07-31 | -- | -2.51% |
| 2024/Q1 | 2024-05-01 | -- | +2.73% |
| 2023/Q3 | 2023-11-01 | -- | -3.14% |
Quote time 2026-09-23 14:59:54 · For reference only, not investment advice.